| Dr Velupillai Wignakumar, MD, FRCS | |
|
80 Hospital Dr, Barbourville, KY 40906-7363 | |
| (606) 545-5539 | |
| (606) 545-5591 |
| Full Name | Dr Velupillai Wignakumar |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 80 Hospital Dr, Barbourville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265495063 | NPI | - | NPPES |
| 64027055 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | KY34425 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pineville Community Health Center, Inc | Pineville, KY | Hospital |
| Entity Name | Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831150119 PECOS PAC ID: 4486616141 Enrollment ID: O20041103001183 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
| Entity Name | Yalinie Medics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992964944 PECOS PAC ID: 5991938557 Enrollment ID: O20140506000690 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
| Entity Name | Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255471827 PECOS PAC ID: 4486616141 Enrollment ID: O20141210002155 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
| Entity Name | Pineville Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275192924 PECOS PAC ID: 5698009157 Enrollment ID: O20200116003024 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
| Entity Name | Pineville Er Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578194890 PECOS PAC ID: 1153743075 Enrollment ID: O20200623002281 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Velupillai Wignakumar, MD, FRCS 1625 Nicholasville Road, Suite 201, Lexington, KY 40503 Ph: (859) 619-1372 | Dr Velupillai Wignakumar, MD, FRCS 80 Hospital Dr, Barbourville, KY 40906-7363 Ph: (606) 545-5539 |
News Archive
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius sent a letter to Chairman George Miller and the Committee on Education and Labor regarding the Government Accountability Office (GAO) investigation into improper practices by Head Start grantees. The investigation is the subject of the Committee's upcoming hearing. Secretary Sebelius' letter outlines HHS's plans and steadfast commitment to upholding the integrity of this critical program.
When President Clinton proposed requiring all Americans to buy insurance in the early 1990s, the non-partisan Congressional Budget Office called it "an unprecedented form of federal action," adding that "[t]he government has never required people to buy any good or service as a condition of lawful residence in the United States," the Los Angeles Times reports.
The U.S. Food and Drug Administration today approved Idelvion, Coagulation Factor IX (Recombinant), Albumin Fusion Protein, for use in children and adults with Hemophilia B. Idelvion is the first coagulation factor-albumin fusion protein product to be approved, and the second Factor IX fusion protein product approved in the U.S. that is modified to last longer in the blood.
New research released today in Nature Neuroscience reveals for the first time that pain is processed in male and female mice using different cells. These findings have far-reaching implications for our basic understanding of pain, how we develop the next generation of medications for chronic pain—which is by far the most prevalent human health condition—and the way we execute basic biomedical research using mice.
› Verified 9 days ago
Mr. Jerry L Woolum, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 80 Hospital Dr Ste 2, Barbourville, KY 40906 Phone: 606-545-4460 Fax: 606-545-4469 |